Skip to main content
Equibles

Invesco Ltd.

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,614,079
-$855,291 QoQ
Shares Held
143,552
-41.2% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 183 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. CGEM ranks #107 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in CGEM

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,614,079 143,552
2026-03-31 $3,469,370 244,150
2025-12-31 $1,348,841 130,323
2025-09-30 $606,708 102,312
2025-06-30 $455,977 60,555
2025-03-31 $372,767 49,243
2024-12-31 $725,354 59,553
2024-09-30 $973,562 58,158
2024-06-30 $860,855 49,361
2024-03-31 $807,814 47,407
2023-12-31 $108,247 10,623
2022-12-31 $106,099 10,057
2022-09-30 $129,904 10,133
2022-06-30 $129,660 10,114
2022-03-31 $123,900 11,834
2021-12-31 $179,464 11,631
2021-09-30 $205,995 9,127